van Montfoort J E, Müller M, Groothuis G M, Meijer D K, Koepsell H, Meier P J
Department of Pharmacokinetics and Drug Delivery, Groningen University Institute for Drug Exploration, Groningen, The Netherlands.
J Pharmacol Exp Ther. 2001 Jul;298(1):110-5.
Previous inhibition studies with taurocholate and cardiac glycosides suggested the presence of separate uptake systems for small "type I" (system1) and for bulky "type II" (system2) organic cations in rat hepatocytes. To identify the transport systems involved in type I and type II organic cation uptake, we compared the organic cation transport properties of the rat and human organic cation transporter 1 (rOCT1; hOCT1) and of the organic anion-transporting polypeptides 2 and A (rat Oatp2; human OATP-A) in cRNA-injected Xenopus laevis oocytes. Based on characteristic cis-inhibition patterns of rOCT1-mediated tributylmethylammonium and Oatp2-mediated rocuronium uptake, rOCT1 and Oatp2 could be identified as the organic cation uptake systems1 and 2, respectively, in rat liver. While hOCT1 exhibited similar transport properties as rOCT1, OATP-A- but not Oatp2-mediated rocuronium uptake was inhibited by the OATP-A substrate N-methyl-quinidine. The latter substrate was also transported by rOCT1 and hOCT1, demonstrating distinct organic cation transport activities for rOCT1 and Oatp2 and overlapping organic cation transport activities for hOCT1 and OATP-A. Finally, the data demonstrate that unmethylated quinidine is transported by rOCT1, hOCT1, and OATP-A at pH 6.0, but not at pH 7.5, indicating that quinidine requires a positive charge for carrier-mediated uptake into hepatocytes. In conclusion, the studies demonstrate that in rat liver the suggested organic cation uptake systems1 and 2 correspond to rOCT1 and Oatp2, respectively. However, the rat-based type I and II organic cation transporter classification cannot be extended without modification from rat to human.
先前使用牛磺胆酸盐和强心苷进行的抑制研究表明,大鼠肝细胞中存在针对小分子“ I型”(系统1)和大分子“ II型”(系统2)有机阳离子的独立摄取系统。为了确定参与I型和II型有机阳离子摄取的转运系统,我们比较了大鼠和人类有机阳离子转运体1(rOCT1;hOCT1)以及有机阴离子转运多肽2和A(大鼠Oatp2;人类OATP-A)在注射了cRNA的非洲爪蟾卵母细胞中的有机阳离子转运特性。基于rOCT1介导的三丁基甲基铵摄取和Oatp2介导的罗库溴铵摄取的特征性顺式抑制模式,rOCT1和Oatp2可分别被鉴定为大鼠肝脏中的有机阳离子摄取系统1和2。虽然hOCT1表现出与rOCT1相似的转运特性,但OATP-A底物N-甲基奎尼丁抑制了OATP-A介导的罗库溴铵摄取,而不是Oatp2介导的摄取。后一种底物也可被rOCT1和hOCT1转运,表明rOCT1和Oatp2具有不同的有机阳离子转运活性,而hOCT1和OATP-A具有重叠的有机阳离子转运活性。最后,数据表明未甲基化的奎尼丁在pH 6.0时可被rOCT1、hOCT1和OATP-A转运,但在pH 7.5时则不能,这表明奎尼丁需要带正电荷才能通过载体介导摄取到肝细胞中。总之,这些研究表明,在大鼠肝脏中,所提出的有机阳离子摄取系统1和2分别对应于rOCT1和Oatp2。然而,基于大鼠的I型和II型有机阳离子转运体分类未经修改就不能从大鼠扩展到人类。